Aging Population and Pipeline Launches Fuel Rapid Growth in Ophthalmic Pharma MarketDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Ophthalmic Drugs Market Report 2025-2035" has been added to ...
Preliminary Fourth Quarter and Full Year 2024 ORLADEYO Revenue and Total Revenue, and 2025 ORLADEYO and Total Revenue Outlook Preliminary, unaudited ORLADEYO net revenue in the fourth quarter of 2024 ...
WATERTOWN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of ...
Phase 1b clinical data underpins sozinibercept's potential as a novel, first-in-class VEGF-C/D 'trap' to improve visual and anatomic outcomes in DME< ...
AN AVIATION expert has suggested a “sinister” possible cause of the catastrophic South Korean aeroplane crash that killed 179 people. Meanwhile, police have raided the airport where the plane ...
While these medications are used to reduce pain, inflammation, and fever, over time they can cause changes to the blood that raise the chances of heart attacks and strokes. If taken in high doses ...
money that was used to advance an asset for diabetic macular edema, a retinal disease that can cause blindness. The candidate, dubbed OXU-001, is designed to deliver a sustained release ...
There are treatments to slow the progression of DME and prevent further vision loss. Diabetic macular edema (DME) is a complication of diabetes. It happens when high blood sugar levels cause ...